News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Stephanie Pilat, PharmD

Articles by Stephanie Pilat, PharmD

The Adalimumab Biosimiliar Pipeline: What's Ahead

ByStephanie Pilat, PharmD,Viktoriya Avlasevich, PharmD,Lisa Cristofaro, PharmD, BS, BCACP

July 21st 2023

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.

Latest Updated Articles

Trending on Dermatology Times

Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025

The Rx Recap: December 14-19

The Aesthetic Edge: December 2025

Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis

The Weekly Roundup: December 15-19